Xcout IntelSign inSubscribe

Indoco Remedies Limited competitors & alternatives

INDOCOPharmaceuticalsMumbai, India

The 12 closest competitors and alternatives to Indoco Remedies Limited among pharmaceuticals companies — ranked by similarity to what Indoco Remedies Limited actually does, not by market-cap band.

$210.9MMarket cap
6,000Employees
12Competitors listed

Subscribe to see Indoco Remedies Limited’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Indoco Remedies Limited

Indoco Remedies Limited, an Indian pharmaceutical company founded in Mumbai in 1945 (originally known as Indo Continental Trading Company), operates globally, manufacturing and distributing a broad spectrum of finished drug formulations and active pharmaceutical ingredients (APIs). The company's extensive product portfolio addresses diverse therapeutic areas: Respiratory conditions: with offerings like Karvol Plus, Febrex Plus, and Tuspel. Oral and dental care (stomatologicals): including Sensodent-K, Sensoform Toothpaste, the Rexidin series, and Snowdent. Gastrointestinal ailments: featuring products such as Carmicide, Cyclopam, and Nosic. Pain relief/analgesics: exemplified by Lignox and T-lac. Ophthalmic and otic solutions: comprising items like Renolen, Dexoren – S, and the Mofloren range. Vitamins, minerals, and nutritional supplements: such as Methycal, MCBM DHA, and Apispur. Urological treatments: including Carmicide and Cital. Dermatological preparations: like Cloben G and Scabex. Anti-infective agents: represented by ATM. Blood-related therapies: such as Hemsyl. Gynecological health products: including MCBM 69 and D Chiro. Anti-haemorrhoidal treatments: with Spear. Beyond its pharmaceutical manufacturing, Indoco Remedies provides comprehensive analytical services. These include impurity profiling, particle size analysis, heavy metal analysis, polymorphism studies, compatibility and stability assessments (like extractables/leachables and lyophilization), and advanced chromatographic method development and validation. Furthermore, the company offers a suite of engineering and project management services. This covers architectural and structural design, mechanical and electrical engineering, lighting solutions, control system integration, piping design, data transfer systems, and holistic project and construction management for process facilities. Indoco Remedies serves a wide range of medical professionals, from general practitioners and pediatricians to specialized consultants like dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists.

Indoco Remedies Limited at a glance

Indoco Remedies Limited is a pharmaceuticals company headquartered in Mumbai, India. It is publicly listed (INDOCO) with a market capitalisation of $210.9M. Xcout tracks 7 named people at Indoco Remedies Limited, including Aditi Kare Panandikar (Managing Director).

Indoco Remedies Limited leadership

  • Aditi Kare PanandikarManaging Director
  • Sundeep V. BambolkarJt. Managing Director
  • Suresh G. KareChairman
  • Abhijit Yashwant GoreIndependent Director
  • Ajay MulgaokarIndependent Director
  • Satish ShenoyIndependent Director

1 more named person on record for Indoco Remedies Limited, with roles, board committees and tenure — see the full roster →

Top 12 Indoco Remedies Limited competitors

Ranked by semantic similarity — how close each company is to Indoco Remedies Limited by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Lupin LimitedLUPIN · PharmaceuticalsMumbai, India
68% matchPublic

Similar pharmaceuticals company

Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.

Market cap$11.6B
Employees19,210
Lupin Limited competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Indoco Remedies Limited and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Indoco Remedies Limitedand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →